Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AML and High Risk MDS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07607418
What this trial is testing

Ivosidenib as Maintenance Therapy in Transplant-Ineligible IDH1-mutated AML and HR-MDS

Who this might be right for
AML (Acute Myeloid Leukemia)MDS (Myelodysplastic Syndrome)
Ruijin Hospital 20
Testing effectiveness (Phase 2)Study completedNCT02842827
What this trial is testing

Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) 45
Early research (Phase 1)Looking for participantsNCT02203903
What this trial is testing

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

Who this might be right for
Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS
Catherine Bollard 50
Testing effectiveness (Phase 2)Study completedNCT00954941
What this trial is testing

Ondansetron Versus Aprepitant Plus Ondansetron for Emesis

Who this might be right for
Hematologic DiseasesAcute Myelogenous LeukemiaMyelodysplastic Syndrome+1 more
M.D. Anderson Cancer Center 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07214064
What this trial is testing

Venetoclax- Augmented Treosulfan-Based Reduced Intensity Conditioning Before Allogeneic Stem Cell Transplantation

Who this might be right for
AML (Acute Myeloid Leukemia)MDS/AMLMDS (Myelodysplastic Syndrome)
University Hospital Tuebingen 27
Large-scale testing (Phase 3)Study completedNCT00152139
What this trial is testing

Stem Cell Transplantation for Patients With Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiasAcute Myelocytic LeukemiaChronic Myeloid Leukemia+4 more
St. Jude Children's Research Hospital 33
Testing effectiveness (Phase 2)Study completedNCT00195000
What this trial is testing

Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Weill Medical College of Cornell University 43
Testing effectiveness (Phase 2)Ended earlyNCT01640301
What this trial is testing

Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant

Who this might be right for
Recurrent Adult Acute Myeloid LeukemiaRecurrent Childhood Acute Myeloid LeukemiaSecondary Acute Myeloid Leukemia+5 more
Fred Hutchinson Cancer Center 47
Testing effectiveness (Phase 2)Looking for participantsNCT06839456
What this trial is testing

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Who this might be right for
LeukemiaHigh Risk Acute Lymphoblastic LeukemiaHigh Risk Acute Myeloid Leukemia+11 more
Children's Hospital of Philadelphia 100
Testing effectiveness (Phase 2)Looking for participantsNCT07582172
What this trial is testing

Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia With Complex KaryotypeMyelodysplastic Chronic Myelomonocytic LeukemiaMyelodysplastic Syndrome+8 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT00867308
What this trial is testing

Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage Dysplasia

Who this might be right for
Myelodysplastic Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32
Early research (Phase 1)Not Yet RecruitingNCT07780565
What this trial is testing

Study of Monzosertib In Patients With R/R AML Or High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome
M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)Looking for participantsNCT06717958
What this trial is testing

Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Neoplasia With IDH1 (Isocitrate Dehydrogenase 1) Mutation

Who this might be right for
AMLMDS
Technische Universität Dresden 76
Testing effectiveness (Phase 2)UnknownNCT05066958
What this trial is testing

Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

Who this might be right for
Acute Myeloid LeukemiaHigh Risk Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia, in Relapse+4 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 20
Testing effectiveness (Phase 2)Study completedNCT01019317
What this trial is testing

Fludarabine and Cytarabine in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
LeukemiaAMLMDS+1 more
M.D. Anderson Cancer Center 151
Testing effectiveness (Phase 2)Ended earlyNCT00818649
What this trial is testing

Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 16
Not applicableStudy completedNCT00060021
What this trial is testing

Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation

Who this might be right for
Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT03067571
What this trial is testing

Daratumumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
High Risk Myelodysplastic SyndromeRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07575412
What this trial is testing

SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMDS+4 more
The First Affiliated Hospital of Soochow University 180
Testing effectiveness (Phase 2)Study completedNCT02215070
What this trial is testing

Pasireotide in Prevention of GI Toxicity

Who this might be right for
Hematological Malignancies
Anthony Sung, MD 37
Next Page
35